If you often feel tired, foggy, or have trouble focusing, you've likely already tried getting more sleep, eating better, cutting back on caffeine, and exercising more. But if these basics haven't fixed the problem, you may be searching for other answers. NAD+ is now seen as a promising, research-supported way to address these issues at the cellular level. Here's what studies have found.
Why Energy Declines with Age
Most of your body's energy comes from the mitochondria, the power plants inside your cells. They turn food into ATP, which fuels your muscles and brain. NAD+ is needed for this process because it helps move electrons in the metabolic chain. As you get older, NAD+ levels go down, so mitochondria work less efficiently and make less ATP. This leaves your cells with less energy, which can make you feel tired and sluggish.
The NAD-Fatigue Connection
Studies have shown that lower NAD+ levels are linked to problems with mitochondria, which is common as we age. One important study in Cell found that raising NAD+ levels in older mice reversed these problems and improved their energy use to levels seen in younger mice. While results in mice don't always apply to people, the basic biology is similar, and early research in humans is showing similar trends.
For men dealing with NAD fatigue—the kind of tiredness that sleep alone doesn't fix—this connection offers a plausible explanation and a potential intervention point.
NAD+ and Mental Clarity
The brain is one of the most energy-demanding organs in your body, consuming roughly 20 percent of your total energy despite representing only about 2 percent of your body weight. When mitochondrial function declines, the brain feels it acutely. NAD mental clarity connections are supported by research showing that NAD+ plays roles in neuronal energy metabolism, synaptic plasticity, and neurotransmitter regulation. Animal studies have demonstrated that boosting NAD+ levels can protect against age-related cognitive decline and improve neurological function.
Patients who undergo NAD+ therapy frequently report that improved mental clarity is among the first benefits they notice—often within the first week or two. They describe it as a lifting of fog, an ability to focus more easily, and less mental effort required for tasks that had been feeling difficult.
What the Clinical Observations Show
While large-scale human trials specifically testing NAD+ therapy for energy and cognition are still in progress, clinical observations from providers administering NAD+ therapy consistently describe improvements in sustained energy throughout the day, reduced reliance on caffeine and other stimulants, better focus and cognitive performance, improved mood and motivation, and reduced recovery time after physical and mental exertion.
These observations align with what the basic science predicts: if you restore the cofactor your mitochondria need to produce energy efficiently, energy production improves.
NAD+ as Part of a Bigger Strategy
NAD+ therapy isn't a replacement for the fundamentals of good health. Sleep, nutrition, exercise, and stress management remain the foundation of energy and cognitive performance. What NAD+ offers is support at the cellular level—helping your mitochondria function more effectively so that the healthy habits you're already practicing can produce better results.
If persistent fatigue or brain fog is affecting your quality of life despite addressing the basics, NAD+ therapy may be worth exploring. At HRT Wellness, we help patients evaluate whether NAD+ supplementation could be a useful addition to their health plan. Reach out to schedule a consultation.
References
- Gomes AP, et al. Declining NAD+ induces a pseudohypoxic state, disrupting nuclear-mitochondrial communication during aging. Cell. 2013;155(7):1624–1638.
- Yoshino J, Baur JA, Imai S. NAD+ intermediates: the biology and therapeutic potential of NMN and NR. Cell Metabolism. 2018;27(3):513–528.
- Braidy N, et al. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets. Antioxidants & Redox Signaling. 2019;30(2):187–208.